Navigation Links
Insurance Company Includes Global Network Option in Limited Benefit Plans
Date:6/4/2008

COLUMBIA, S.C., June 4 /PRNewswire-USNewswire/ -- BasicPlus Health Insurance of Roswell, Ga., announced today that it has entered into an agreement with Companion Global Healthcare Inc. of Columbia, S.C., to include a network of accredited, overseas hospitals in its most popular limited benefit health insurance plans.

The agreement means those enrolled in BasicPlus' FlexMed (for employers) and BasicPlus (for individuals) limited benefit plans have the option of seeking surgery and other covered services at hospitals in Companion Global Healthcare's network. All of the network's hospitals hold the prestigious Joint Commission International (JCI) accreditation, and all offer a range of services at rates lower than those typically charged in the United States.

FlexMed and BasicPlus members treated overseas will receive Companion Global Healthcare's concierge medical travel services, including assistance with scheduling appointments and arranging travel.

Chuck Green, CEO of BasicPlus, said, "Since our members have fixed benefit maximums, the inclusion of Companion Global Healthcare's option into our products allows members to limit their out-of-pocket payments while availing themselves to JCI-accredited hospitals in foreign locations."

"To our knowledge, this is the first fully insured, limited benefit product with a global health care benefit included," said Robert Rhodes, chief operating officer of TCC of South Carolina, the third-party insurance administrator that supports the BasicPlus product line. "This arrangement will help FlexMed and BasicPlus members dramatically stretch their limited benefit plan dollars."

Companion Global Healthcare President David Boucher said his company's network of overseas hospitals is a helpful addition for limited benefit plans.

"While many limited benefit plans provide coverage for basic health care, most would cover only a small portion of the bill for a lengthy inpatient hospital sta
'/>"/>

SOURCE Companion Global Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Philadelphia Insurance Companies Launches Home Health Care and Hospice Products
2. AMA Insurance Agency Announces Launch of Consultations(SM)
3. Insurance Companies Rejecting Women With History of Cesarean
4. More Young People Going Without Health Insurance
5. Long Term Care Insurance Leader Goes Green, Targeting a Million Gallons of Gasoline Saved Per Year
6. Young adults at risk: 13.7 million lack health insurance coverage
7. ACP releases framework for policies enabling access to affordable health insurance coverage
8. Does Your Child Have Health Insurance? Urban League of Philadelphia Announces Free Open Houses for CHIP Enrollment
9. Best Practices Insurance Services Announces Key Additions to Senior Management
10. National Business Group on Health Honors Erie Insurance As One of Best Employers for Healthy Lifestyles
11. Dont Wait for the Election to Plan Your Long-Term Healthcare, Insurance Leader Advises
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 1Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 1President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 3St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 1St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 2